Literature DB >> 19931629

Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.

Andreas Friedl1.   

Abstract

Reciprocal interactions between tumor and stromal cells govern carcinoma growth and progression. Signaling functions between these cell types in the tumor microenvironment are largely carried out by secreted growth factors and cytokines. This review discusses how proteoglycans, which are abundantly present in normal and neoplastic tissues, modulate paracrine growth factor signaling events. General principles of proteoglycan involvement in paracrine signaling include stromal induction, core protein processing by proteases and growth factor binding via proteoglycan glycosaminoglycan chains or core protein domains. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931629      PMCID: PMC2824000          DOI: 10.1016/j.semcdb.2009.11.013

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  87 in total

1.  Cancer. Respect thy neighbor!

Authors:  Derek C Radisky; Mina J Bissell
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

2.  Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.

Authors:  Zhongjun Zhou; Jianming Wang; Renhai Cao; Hiroyuki Morita; Raija Soininen; Kui Ming Chan; Baohua Liu; Yihai Cao; Karl Tryggvason
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

3.  Prognostic value of syndecan-1 expression in breast cancer.

Authors:  Marja Leivonen; Johan Lundin; Stig Nordling; Kristina von Boguslawski; Caj Haglund
Journal:  Oncology       Date:  2004       Impact factor: 2.935

4.  Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.

Authors:  Xiaochong Wu; Chengliu Jin; Fen Wang; Chundong Yu; Wallace L McKeehan
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

5.  Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.

Authors:  Takashi Maeda; Caroline M Alexander; Andreas Friedl
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

6.  A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.

Authors:  Eva M Gonzalez; Maurizio Mongiat; Simon J Slater; Raffaele Baffa; Renato V Iozzo
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

7.  Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.

Authors:  Kazuhira Endo; Takahisa Takino; Hisashi Miyamori; Hidenori Kinsen; Tomokazu Yoshizaki; Mitsuru Furukawa; Hiroshi Sato
Journal:  J Biol Chem       Date:  2003-08-06       Impact factor: 5.157

8.  Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.

Authors:  E June Davies; Fiona H Blackhall; Jonathan H Shanks; Guido David; Alan T McGown; Ric Swindell; Richard J Slade; Pierre Martin-Hirsch; John T Gallagher; Gordon C Jayson
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

Review 9.  Syndecans in tumor cell adhesion and signaling.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

10.  The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells.

Authors:  DeannaLee M Beauvais; Brandon J Burbach; Alan C Rapraeger
Journal:  J Cell Biol       Date:  2004-10-11       Impact factor: 10.539

View more
  3 in total

Review 1.  The extracellular matrix at a glance.

Authors:  Christian Frantz; Kathleen M Stewart; Valerie M Weaver
Journal:  J Cell Sci       Date:  2010-12-15       Impact factor: 5.285

Review 2.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Proteoglycans in prostate cancer.

Authors:  Iris J Edwards
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.